Cargando…

The role of RANK ligand/OPG system in bone erosions in rheumatoid arthritis

Detalles Bibliográficos
Autor principal:	Geusens, Piet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3353581/ http://dx.doi.org/10.1186/ar3720

Ejemplares similares

Local IL-17 gene therapy accelerates collagen arthritis with severe bone erosion and rank ligand and rank expression in synovial infiltrate and at bone erosion sites
por: Lubberts, E, et al.
Publicado: (2001)

Histopathology of Bone Erosions in Rheumatoid Arthritis
por: Gravallese, Ellen, et al.
Publicado: (2000)

Pathophysiology of subchondral bone erosions in rheumatoid arthritis
por: Schett, Georg
Publicado: (2012)

Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-TNF in combination with OPG or PTH in TNF-mediated arthritis
por: Redlich, K, et al.
Publicado: (2004)

Anti-tumour necrosis factor therapy modulates the OPG/OPGL system in rheumatoid arthritis synovium
por: Catrina, AI, et al.
Publicado: (2004)

OPG and RANKL in serum and synovial fluids of patients with rheumatoid arthritis, osteoarthritis and spondylarthropathy
por: Krystufkova, O, et al.
Publicado: (2003)

TRAIL-induced rheumatoid arthritis fibroblast-like synoviocyte proliferation is inhibited by OPG
por: Morel, J, et al.
Publicado: (2004)

CD44 regulates bone erosion and osteoclastogenesis in arthritis
por: Hayer, S, et al.
Publicado: (2004)

Neutralizing synovial RANKL by local OPG gene therapy in collagen-induced arthritis prevents cartilage erosion through induction of a non-destructive type 2 synovitis
por: Lubberts, E, et al.
Publicado: (2004)

IL-18 correlates positively with CRP and IL-1Ra but not with DAS28 or bone erosion in patients with rheumatoid arthritis
por: Nielsen, H, et al.
Publicado: (2002)

Treatment with OPG and cellular gene therapy with IL-4 decrease bone resorption-associated inflammation in collagen-induced arthritis
por: Saidenberg-Kermanac'h, N, et al.
Publicado: (2003)

Protection of inflammation-related bone loss by OPG and TNF-α antibodies through distinct mechanisms in collagen-induced arthritis
por: Saidenberg-Kermanach, N, et al.
Publicado: (2004)

Triptolide Prevents Bone Destruction in the Collagen-Induced Arthritis Model of Rheumatoid Arthritis by Targeting RANKL/RANK/OPG Signal Pathway
por: Liu, Chunfang, et al.
Publicado: (2013)

Association between RANK, RANKL and OPG polymorphisms with ACPA and erosions in rheumatoid arthritis: results from a meta-analysis involving three French cohorts
por: Ruyssen-Witrand, Adeline, et al.
Publicado: (2016)

Biology of the RANKL–RANK–OPG System in Immunity, Bone, and Beyond
por: Walsh, Matthew C., et al.
Publicado: (2014)

RANK and RANKL expression in rheumatoid arthritis synovium and lymph nodes as markers of dendritic cell – T cell interactions
por: Page, G, et al.
Publicado: (2004)

Salvianolate Ameliorates Osteopenia and Improves Bone Quality in Prednisone-Treated Rheumatoid Arthritis Rats by Regulating RANKL/RANK/OPG Signaling
por: Gao, Xiang, et al.
Publicado: (2021)

Requirement of local synovial IL-17 receptor signaling in the progression of chronic synovitis and bone erosion in arthritis
por: Lubberts, E, et al.
Publicado: (2004)

RANK/RANKL/OPG system in the intervertebral disc
por: Takegami, Norihiko, et al.
Publicado: (2017)

TNF polymorphisms are associated with the development of joint erosions in psoriatic arthritis
por: Kane, D, et al.
Publicado: (2003)

The significance of antibodies to cyclic citrullinated peptide, antikeratin antibodies, anti-perinuclear factor, rheumatoid factor isotypes and HLA shared epitope in prediction of erosive disease in early rheumatoid arthritis patients
por: Vencovsky, J, et al.
Publicado: (2001)

Osteoprotegerin (OPG) gene therapy in animal models of osteoarticular disease
por: Bolon, B, et al.
Publicado: (2001)

Damage progression in rheumatoid arthritis: the role of biologic agents
por: Favalli, Ennio Giulio
Publicado: (2012)

Dendritic Cells: What Is Their True Role in Rheumatoid Arthritis?
por: Thomas, R, et al.
Publicado: (2000)

The Role of COX-2 in Rheumatoid Arthritis Synovial Tissues
por: Crofford, Leslie J
Publicado: (2000)

Genetics of Rheumatoid Arthritis
por: Nepom, Gerald T
Publicado: (2000)

Chemokines in Rheumatoid Arthritis
por: Koch, Alisa
Publicado: (2000)

Predictors of Early Bone Erosion in Patients With Synovitis of Recent Onset
por: Lee, J, et al.
Publicado: (2000)

The RANK/RANKL/OPG system and tumor bone metastasis: Potential mechanisms and therapeutic strategies
por: Zhang, Yan, et al.
Publicado: (2022)

Soy Isoflavones and Bone Health: Focus on the RANKL/RANK/OPG Pathway
por: Hooshiar, Saeedeh Hosseini, et al.
Publicado: (2022)

Isolated and combined inhibition of TNF-, IL-1 and RANKL-pathways in TNF-induced arthritis: effects on synovial inflammation, bone erosion and cartilage destruction
por: Zwerina, J, et al.
Publicado: (2003)

Autoreactivity patterns in rheumatoid arthritis
por: Behrens, S, et al.
Publicado: (2001)

Etanercept for Treating Rheumatoid Arthritis
por: Moreland, Larry W
Publicado: (2000)

The association between RANK, RANKL and OPG gene polymorphisms and the risk of rheumatoid arthritis: a case-controlled study and meta-analysis
por: Yang, Haoyu, et al.
Publicado: (2019)

Anti-BIP antibodies in rheumatoid arthritis
por: Panayi, GS, et al.
Publicado: (2003)

Fibrinogen-specific T cells in rheumatoid arthritis
por: Vossenaar, E, et al.
Publicado: (2003)

Dendritic cell subsets in rheumatoid arthritis
por: Summers, K, et al.
Publicado: (2001)

Synovial Histopathology in Early Rheumatoid Arthritis
por: Hirohata, Shunsei, et al.
Publicado: (2000)

Activation of Synovial Fibroblasts in Rheumatoid Arthritis
por: Gay, Steffen, et al.
Publicado: (2000)

RANKL/RANK/OPG system beyond bone remodeling: involvement in breast cancer and clinical perspectives
por: Infante, Marco, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ga1p46abam3ql5jsab8cg28glb